Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-finding Phase I Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis

NCT07245992 is registered in ClinicalTrials.gov with Philogen S.p.A. as lead sponsor.

NCT NCT07245992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07245992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-finding Phase I Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
Lead sponsor
Philogen S.p.A.
Phase
Phase 1
Overall status
Recruiting
Start date
March 4, 2026
Completion date
September 30, 2029
Enrollment
54 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis (ra)